Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice

Endocrinology

Volumn 151, Issue 8, 2010, Pages 3536-3542

  Wende, Adam R ^a   Soto, Jamie ^a   Olsen, Curtis D ^a   Pires, Karla M P ^a,b   Schell, John C ^a   Larrieu Lahargue, Frederic ^a   Litwin, Sheldon E ^a   Kakoki, Masao ^c   Takahashi, Nobuyuki ^c   Smithies, Oliver ^c   Abel, E Dale ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; FEMALE; HEART CONTRACTION; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; BRADYKININ; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; HEART; HEART DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA, HEART; MYOCARDIUM; OXIDATIVE STRESS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 77954930286     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0256     Document Type: Article

References (30)

1. Duka I, Shenouda S, Johns C, Kintsurashvili E, Gavras I, Gavras H 2001 Role of the B2 receptor of bradykinin in insulin sensitivity. Hypertension 38:1355-1360 (Pubitemid 34033415)
2. Spillmann F, Van Linthout S, Schultheiss HP, Tschöpe C 2006 Cardioprotective mechanisms of the kallikrein-kinin system in diabetic cardiopathy. Curr Opin Nephrol Hypertens 15:22-29
3. Spillmann F, Altmann C, Scheeler M, Barbosa M, Westermann D, Schultheiss HP, Walther T, Tschöpe C 2002 Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload- induced cardiomyopathy. Int Immunopharmacol 2:1823-1832
4. Yoshida H, Zhang JJ, Chao L, Chao J 2000 Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension 35:25-31 (Pubitemid 30054232)
5. Chao J, Yin H, Gao L, Hagiwara M, Shen B, Yang ZR, Chao L 2008 Tissue kallikrein elicits cardioprotection by direct kinin B2 receptor activation independent of kinin formation. Hypertension 52:715-720
6. Yao YY, Yin H, Shen B, Chao L, Chao J 2007 Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regul Pept 140:12-20 (Pubitemid 46275053)
7. Mikrut K, Paluszak J, Kozlik J, Sosnowski P, Krauss H, Grześkowiak E 2001 The effect of bradykinin on the oxidative state of rats with acute hyperglycaemia. Diabetes Res Clin Pract 51:79-85 (Pubitemid 32140860)
8. Montanari D, Yin H, Dobrzynski E, Agata J, Yoshida H, Chao J, Chao L 2005 Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats. Diabetes 54:1573-1580 (Pubitemid 40586692)
9. Tschöpe C, Walther T, Escher F, Spillmann F, Du J, Altmann C, Schimke I, Bader M, Sanchez-Ferrer CF, Schultheiss HP, Noutsias M 2005 Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction, and oxidative stress in experimental diabetic cardiomyopathy. FASEB J 19:2057-2059
10. Emanueli C, Maestri R, Corradi D, Marchione R, Minasi A, Tozzi MG, Salis MB, Straino S, Capogrossi MC, Olivetti G, Madeddu P 1999 Dilated and failing cardiomyopathy in bradykinin B2 receptor knockout mice. Circulation 100:2359-2365
11. Kakoki M, Takahashi N, Jennette JC, Smithies O 2004 Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci USA 101:13302-13305 (Pubitemid 39209660)
12. Xu J, Carretero OA, Sun Y, Shesely EG, Rhaleb NE, Liu YH, Liao TD, Yang JJ, Bader M, Yang XP 2005 Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction. Hypertension 45:747-753 (Pubitemid 40418376)
13. Ni A, Yin H, Agata J, Yang Z, Chao L, Chao J 2003 Overexpression of kinin B1 receptors induces hypertensive response to Des-Arg9-bradykinin and susceptibility to inflammation. J Biol Chem 278:219-225 (Pubitemid 36043565)
14. Westermann D, Walther T, Savvatis K, Escher F, Sobirey M, Riad A, Bader M, Schultheiss HP, Tschöpe C 2009 Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy. Diabetes 58:1373-1381
15. Emanueli C, Bonaria Salis M, Stacca T, Pintus G, Kirchmair R, Isner JM, Pinna A, Gaspa L, Regoli D, Cayla C, Pesquero JB, Bader M, Madeddu P 2002 Targeting kinin B1 receptor for therapeutic neovascularization. Circulation 105:360-366
16. Cayla C, Todiras M, Iliescu R, Saul VV, Gross V, Pilz B, Chai G, Merino VF, Pesquero JB, Baltatu OC, Bader M 2007 Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J 21:1689-1698 (Pubitemid 46855614)
17. Kakoki M, McGarrah RW, Kim HS, Smithies O 2007 Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury. Proc Natl Acad Sci USA 104:7576-7581 (Pubitemid 47185948)
18. Bugger H, Boudina S, Hu XX, Tuinei J, Zaha VG, Theobald HA, Yun UJ, McQueen AP, Wayment B, Litwin SE, Abel ED 2008 Type 1 diabetic Akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes 57:2924-2932
19. Yoshioka M, Kayo T, Ikeda T, Koizumi A 1997 A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines earlyonset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46:887-894 (Pubitemid 27188269)
20. Sena S, Rasmussen IR, Wende AR, McQueen AP, Theobald HA, Wilde N, Pereira RO, Litwin SE, Berger JP, Abel ED 2007 Cardiac hypertrophy caused by peroxisome proliferator-activated receptor-γ agonist treatment occurs independently of changes in myocardial insulin signaling. Endocrinology 148:6047-6053
21. McQueen AP, Zhang D, Hu P, Swenson L, Yang Y, Zaha VG, Hoffman JL, Yun UJ, Chakrabarti G, Wang Z, Albertine KH, Abel ED, Litwin SE 2005 Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density. J Mol Cell Cardiol 39:882-892
22. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED 2005 Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112:2686-2695
23. Kim HJ, Yu BP, Chung HY 2002 Molecular exploration of age-related NF-κB/IKK downregulation by calorie restriction in rat kidney. Free Radic Biol Med 32:991-1005
24. Gundersen HJ 1977 Notes on the estimation of the numerical density of arbitrary profiles, the edge effect. J Microsc 111:219-223
25. Mandarim-de-Lacerda CA 2003 Stereological tools in biomedical research. An Acad Bras Cienc 75:469-486
26. Kakoki M, Kizer CM, Yi X, Takahashi N, Kim HS, Bagnell CR, Edgell CJ, Maeda N, Jennette JC, Smithies O 2006 Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors. J Clin Invest 116:1302-1309
27. Yin H, Chao J, Bader M, Chao L 2007 Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides 28:1383-1389
28. Tschöpe C, Westermann D 2008 Development of diabetic cardiomyopathy and the kallikrein-kinin system: new insights from B1 and B2 receptor signaling. Biol Chem 389:707-711
29. Lagneux C, Bader M, Pesquero JB, Demenge P, Ribuot C 2002 Detrimental implication of B1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice. Int Immunopharmacol 2:815-822
30. Duka A, Kintsurashvili E, Duka I, Ona D, Hopkins TA, Bader M, Gavras I, Gavras H 2008 Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors. Hypertension 51:1352-1357